Karen L. Zaderej - 16 Mar 2024 Form 4 Insider Report for Axogen, Inc. (AXGN)

Role
CEO, Director
Signature
/s/ Karen Zaderej
Issuer symbol
AXGN
Transactions as of
16 Mar 2024
Net transactions value
-$301,670
Form type
4
Filing time
25 Mar 2024, 21:43:38 UTC
Previous filing
09 Jan 2024
Next filing
12 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AXGN Common Stock Options Exercise $0 +84,847 +7.9% $0.000000 1,157,593 16 Mar 2024 Direct F1
transaction AXGN Common Stock Sale $253,655 -33,028 -2.9% $7.68 1,124,565 21 Mar 2024 Direct F2
transaction AXGN Common Stock Options Exercise $0 +12,500 +1.1% $0.000000 1,137,065 16 Mar 2024 Direct F1
transaction AXGN Common Stock Sale $23,700 -3,086 -0.27% $7.68 1,133,979 21 Mar 2024 Direct F2
transaction AXGN Common Stock Options Exercise $0 +12,975 +1.1% $0.000000 1,146,954 16 Mar 2024 Direct F1
transaction AXGN Common Stock Sale $24,315 -3,166 -0.28% $7.68 1,143,788 21 Mar 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXGN Restricted Stock Units Options Exercise $0 -84,847 -50% $0.000000 84,847 16 Mar 2024 Common Stock 84,847 Direct F3, F4
transaction AXGN Restricted Stock Units Options Exercise $0 -12,500 -50% $0.000000 12,500 16 Mar 2024 Common Stock 12,500 Direct F3, F5
transaction AXGN Restricted Stock Units Options Exercise $0 -12,975 -100% $0.000000* 0 16 Mar 2024 Common Stock 12,975 Direct F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This reflects the number of restricted stock units that became vested as of March 16, 2024 ..
F2 Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
F3 Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
F4 All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
F5 All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2025 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2023 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
F6 All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.